Roche Holding Company Profile (VTX:ROG)

Roche Holding trades on the VTX under the ticker symbol "ROG."

10 analysts have issued 1 year target prices for Roche Holding's stock. Their predictions range from CHF 215 to CHF 335. On average, they anticipate Roche Holding's stock price to reach CHF 273 in the next twelve months. View Analyst Ratings for Roche Holding.

Some companies that are related to Roche Holding include Partnership Assurance Group PLC (PA), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), Merck KGaA (MKGAY), Shire PLC (SHP), Hospira (HSP), Smith & Nephew plc (SN), Omnicare (OCR), Seattle Genetics (SGEN), Bioverativ (BIVV), ConvaTec Group PLC (CTEC), Mediclinic International PLC (MDC), Health Net (HNT), Patheon NV (PTHN), Masimo (MASI), Bruker (BRKR), Catalent (CTLT) and NMC Health PLC (NMC).

Roche Holding's management team includes the folowing people:

• Severin Schwan, Chairman of the Corporate Executive Committee, Chief Executive Officer, Executive Director
• Alan Hippe, Member of the Corporate Executive Committee, Chief Financial Officer, Information Technology Officer
• Stephan Feldhaus, Member of the Enlarged Corporate Executive Committee, Head Group Communications
• Sophie Kornowski-Bonnet, Member of the Enlarged Corporate Executive Committee, Head Roche Partnering
• Osamu Nagayama, Member of the Enlarged Corporate Executive Committee, Chairman and Chief Executive Officer Chugai
• John C. Reed M.D., Ph.D., Member of the Enlarged Corporate Executive Committee, Head of Roche Pharma Research & Early Development
• Michael David Varney, Member of the Enlarged Corporate Executive Committee, Head Genetech Research and Early Development
• Cristina A. Wilbur, Member of the Executive Committee, Head Group Human Resources
• Urs Jaisli, Chief Compliance Officer
• Gottlieb A. Keller, Member of the Group Executive Committee, General Counsel, Secretary to the Board of Directors